Correlation Between NewAmsterdam Pharma and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Lyra Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Lyra Therapeutics.
Diversification Opportunities for NewAmsterdam Pharma and Lyra Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NewAmsterdam and Lyra is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Lyra Therapeutics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.63 times more return on investment than Lyra Therapeutics. However, NewAmsterdam Pharma is 1.6 times less risky than Lyra Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,941 in NewAmsterdam Pharma on August 25, 2024 and sell it today you would earn a total of 79.00 from holding NewAmsterdam Pharma or generate 4.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.21% |
Values | Daily Returns |
NewAmsterdam Pharma vs. Lyra Therapeutics
Performance |
Timeline |
NewAmsterdam Pharma |
Lyra Therapeutics |
NewAmsterdam Pharma and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NewAmsterdam Pharma and Lyra Therapeutics
The main advantage of trading using opposite NewAmsterdam Pharma and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.NewAmsterdam Pharma vs. Lyra Therapeutics | NewAmsterdam Pharma vs. Hookipa Pharma | NewAmsterdam Pharma vs. SAB Biotherapeutics | NewAmsterdam Pharma vs. Cadrenal Therapeutics, Common |
Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |